China's Top Departments: Cardiology at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Established in 1952 by renowned cardiologists Tao Qing and Gong Lansheng, Ruijin Hospital's Department of Cardiology is a National Key Discipline and National Key Clinical Specialty, consistently ranked among the top 10 cardiology departments nationwide. Comprising the Cardiology Division, Hypertension Division, and the Shanghai Institute of Hypertension, the department is one of China's leading academic and clinical centers in cardiovascular medicine.
What matters most on this page
Short answer:Established in 1952 by renowned cardiologists Tao Qing and Gong Lansheng, Ruijin Hospital's Department of Cardiology is a National Key Discipline and National Key Clinical Specialty, consistently ranked among the top 10 cardiology departments nationwide. Comprising the Cardiology Division, Hypertension Division, and the Shanghai Institute of Hypertension, the department is one of China's leading academic and clinical centers in cardiovascular medicine.
Key points
- National Key Discipline · National Key Clinical Specialty
- Fudan Ranking: Top 10 Nationally (6th–8th in Recent Years)
- Founded 1952 — Over 70 Years of Heritage
- ~350 Beds · 10 DSA Units · 170+ SCI Papers
If you or a loved one is facing a cardiovascular condition — complex coronary disease, arrhythmia, resistant hypertension, heart failure, or structural heart disease — the Department of Cardiology at Ruijin Hospital is among the most prestigious centers in China.
The department was established in 1952 by renowned Chinese cardiologists Tao Qing and Gong Lansheng, and further developed under Professors Qi Wenhang and Shen Weifeng. Today it comprises the Cardiology Division, Hypertension Division, the Institute of Cardiovascular Diseases of Shanghai Jiao Tong University School of Medicine, and the Shanghai Institute of Hypertension, forming one of China's leading academic and clinical centers in cardiovascular medicine.
At Medora, we help international patients navigate Ruijin's cardiology team. Here's what you need to know.
National Recognition & Accreditation
- National Key Discipline of the Ministry of Education (Cardiovascular Medicine) and National Key Clinical Specialty
- One of the first doctoral training programs approved by the Ministry of Education; Key Discipline of the "211 Project" and of the Shanghai Municipal Education Commission
- Consistently ranked among the top 10 cardiology departments nationwide in the Fudan University Annual Hospital Specialty Rankings (ranked 6th–8th nationally in recent years)
- Host institution of the Shanghai Municipal Cardiac Interventional Quality Control Center
- Training base of the Ministry of Health for cardiovascular interventional techniques (coronary intervention / arrhythmia)
- One of the first national demonstration bases for atrial fibrillation interventional training; one of the first national Heart Failure Center construction units
- Shanghai Municipal Ventricular Arrhythmia Diagnosis & Treatment Center (main center); Coronary Heart Disease Diagnosis & Treatment Center of Shanghai Jiao Tong University School of Medicine
- Member of the Shanghai Vascular Biology Key Laboratory, Shanghai Hypertension Key Laboratory, and the State Key Laboratory of Medical Genomics
Expert Team
| Expert | Title / Role | Specialty |
|---|---|---|
| Dr. Zhang Ruiyan | Director of the Department of Cardiology and Chief of the Cardiac Catheterization Laboratory; Chief Physician, Doctoral Supervisor; FACC, FESC, FSCAI; Shanghai Leading Talent | Coronary interventional therapy and peripheral vascular intervention |
| Dr. Wang Jiguang | Director of the Shanghai Institute of Hypertension and Director of the Hypertension Division; Chief Physician, Doctoral Supervisor; President of the Chinese Hypertension League, former Executive Council Member of the International Society of Hypertension, former President of the Asia-Pacific Society of Hypertension | Pioneered an etiological classification approach to hypertension diagnosis and treatment; promoted stratified, staged, and typed management of hypertension, including "smart hypertension treatment centers" |
| Dr. Yan Xiaoxiang | Principal Investigator and Doctoral Supervisor in the Department of Cardiology; recipient of the National Natural Science Foundation of China's Excellent Young Scientists Fund | High-risk complex coronary intervention and critical cardiac care |
The team comprises 3 lifelong professors, 12 senior (full) professors, and 17 associate professors (2020 public data), including nationally recognized mid-career experts, Shanghai Leading Talents, and other high-level talents.
Core Strengths & Signature Procedures
1. Coronary Interventional Therapy
- Emergency primary PCI for acute myocardial infarction
- Complex and high-risk coronary lesions (left main, bifurcation, chronic total occlusion)
- Coronary rotational atherectomy
- Drug-coated balloon therapy
2. Arrhythmia Management
- Three-dimensional electroanatomical mapping-guided catheter ablation (atrial fibrillation, ventricular tachycardia)
- Pacemaker implantation
- Cardiac resynchronization therapy (CRT)
- Implantable cardioverter-defibrillator (ICD) implantation
3. Structural Heart Disease Intervention
- Transcatheter valve procedures and other minimally invasive treatments
4. Precision Hypertension Care
- One of China's earliest hypertension specialty units
- Internationally recognized expertise in the etiological diagnosis and treatment of resistant and secondary hypertension
5. Heart Failure Management
- One of the first national Heart Failure Center construction units
- Standardized comprehensive heart failure care
6. Advanced Non-Invasive Diagnostics
- Echocardiography, magnetocardiography, and other state-of-the-art examination techniques
Scale & Clinical Volume
| Metric | Data |
|---|---|
| Open beds | ~350 |
| DSA units | 10 (internationally advanced equipment) |
| Outpatient visits/year | ~85,000 |
| Interventional procedures/year | 1,500+ |
| Pacemaker implantations/year | ~200 |
| Catheter ablations/year | ~200 |
Research Highlights
- Nearly 62 national and municipal research grants over the past five years (including a Key Project and an Excellent Young Scientists Fund project of the National Natural Science Foundation of China), with total funding of approximately RMB 32.37 million
- More than 170 SCI publications in leading cardiovascular journals including Circulation, JACC, JCI, and Circulation Research
- Recipient of more than 10 awards, including the National Science and Technology Progress Award (Second Class) and the Shanghai Science and Technology Progress Award (Second Class)
Location & Contact
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine No. 197 Ruijin Er Road, Huangpu District, Shanghai 200025, P.R. China
- Hospital switchboard: +86-21-64370045
Shanghai is China's largest city with two international airports (Pudong PVG and Hongqiao SHA), excellent global connectivity, and world-class hospitality infrastructure.
This guide is prepared for an international audience. If you need assistance with medical consultation, appointment booking, or travel arrangements to Ruijin Hospital's Cardiology Department, contact Medora for personalized support.
Need personalized hospital recommendations?
Turn this research into an action plan: get tailored hospital recommendations matched to your condition, budget, and timeline.
✓ Free consultation · Response within 24 hours · 100+ international patients served